Publications by Oncolines Scientists on ResidenceTimer™, QuickScout™
- Grobben et al. (2020) Structural insights into human Arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158. Journal of Structural Biology: X, 4: 100014.
- Libouban et al. (2017) Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell lines, Oncotarget, 8 (24):38309–38325. (collaboration with Netherlands Cancer Institute)
Publications by Oncolines Scientists on Arginase Gold™, NFK Green™
- Grobben et al. (2021) Targeting indoleamine 2,3-dioxygenase in cancer models using the novel small molecule inhibitor NTRC 3883-0, Frontiers in Immunology, section Cancer Immunity and Immunotherapy, online first, January 28, 2021. (collaboration with Radboud University Medical Center)
- Perez-Pardo et al. (2021) Pharmacological validation of TDO as a target for Parkinson’s disease, The FEBS Journal, online first, January 20, 2021. (collaboration with Utrecht University)